Position in CSTL
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$19,918,003
-$4,289,427 QoQ
Shares Held
811,324
+30.4% QoQ
Ownership
2.67%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 73%
Shared 0%
None 27%
Common Shares in CSTL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Allianz Asset Management GmbH holds $601,845,262 across 20 Diagnostics & Research names. CSTL ranks #6 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
418,106 | $205,511,640 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
207,403 | $116,537,670 | |
| 3 | LH |
Labcorp Holdings Inc.
|
214,847 | $57,323,327 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
293,532 | $50,058,945 | |
| 5 | A |
Agilent Technologies, Inc.
|
358,177 | $40,825,013 | |
| 6 | CSTL |
Castle Biosciences Inc
This page
|
811,324 | $19,918,003 | |
| 7 | DHR |
Danaher Corp /De/
|
99,515 | $18,868,043 | |
| 8 | QGEN |
Qiagen N.V.
|
427,030 | $17,098,280 |
All Filings in CSTL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,918,003 | 811,324 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $24,207,430 | 622,299 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $14,762,951 | 648,351 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $14,574,611 | 713,742 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $12,802,328 | 639,477 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $8,591,267 | 322,374 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $2,012,171 | 70,553 | Shares | Defined | 2024-11-13 | |
| 2020-03-31 | $873,999 | 29,319 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||